pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
1,486
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 2
AK-OTOF
Acute Sensorineural Hearing Loss
Akouos Inc
0
catalysts
Phase 2
AK-antiVEGF
Vestibular Schwannoma (Acoustic Neuroma)
Eli Lilly and Co
0
catalysts
Phase 2
AL-001
LiProSal
Bipolar Disorder (Manic Depression)
$ALZN
Alzamend Neuro, Inc.
0
catalysts
Phase 2
ALEP-02
← prev
page 4 of 50
next →
131
Pain
89
Neurology
1
Cervical Cancer
Alentis Therapeutics AG
0
catalysts
Phase 2
ALG-009
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
$ALGS
Aligos Therapeutics, Inc.
0
catalysts
Phase 2
ALG.APV-527
Cervical Cancer
Alligator Bioscience AB
0
catalysts
Phase 2
ALY-101
Alopecia Areata
Alys Pharmaceuticals Inc
0
catalysts
Phase 2
AM-3101
Unspecified Musculoskeletal Disorders
Amplicore Inc
0
catalysts
Phase 2
AMB-051
Tenosynovial Giant Cell Tumor
AmMax Bio Inc
0
catalysts
Phase 2
AMT-162
Amyotrophic Lateral Sclerosis
UniQure NV
0
catalysts
Phase 2
AMT-191
Fabry Disease
UniQure NV
0
catalysts
Phase 2
AMT-260
Epilepsy
UniQure NV
0
catalysts
Phase 2
AMTX-100
Atopic Dermatitis (Atopic Eczema)
Amytrx Therapeutics Inc
0
catalysts
Phase 2
ANAVEX-371
Schizophrenia
$AVXL
ANAVEX LIFE SCIENCES CORP.
0
catalysts
Phase 2
AND-017
Anemia in Chronic Kidney Disease (Renal Anemia)
Kind Pharmaceuticals
0
catalysts
Phase 2
ANS-01
Non-Small Cell Lung Cancer
Avistone Biotechnology Co Ltd
0
catalysts
Phase 2
ANV-419
Metastatic Melanoma
Anaveon AG
0
catalysts
Phase 2
ANV-600
Melanoma
Anaveon AG
0
catalysts
Phase 2
ANXV
Retinal Vein Occlusion
Annexin Pharmaceuticals AB
0
catalysts
Phase 2
AON-D21
Community Acquired Pneumonia
Aptarion Biotech AG
0
catalysts
Phase 2
AP-030
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Apollo Therapeutics Ltd
0
catalysts
Phase 2
AP-101
Amyotrophic Lateral Sclerosis
AL-S Pharma AG
0
catalysts
Phase 2
AP-306
Hyperphosphatemia In Chronic Kidney Disease
R1 Therapeutics Inc
0
catalysts
Phase 2
APC-101
Postherpetic Neuralgia
Andros Pharmaceuticals Co Ltd
0
catalysts
Phase 2
APG-157
Squamous Cell Carcinoma
Aveta Biomics Inc
0
catalysts
Phase 2
APH-0812
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Aphios Corp
0
catalysts
Phase 2
APHD-012
Obesity
Aphaia Pharma AG
0
catalysts
Phase 2
APL-2302
Breast Cancer
Asieris Pharmaceuticals (USA) Inc
0
catalysts
Phase 2
APPA-02
Resistant Pseudomonas aeruginosa Infections
$ARMP
Armata Pharmaceuticals, Inc.
0
catalysts
Phase 2
APS-03118
Medullary Thyroid Cancer
Applied Pharmaceutical Science Inc
0
catalysts
